Calcitonin in the prevention and treatment of osteoporosis

  title={Calcitonin in the prevention and treatment of osteoporosis},
  author={Charles H. Chestnut},
  journal={Osteoporosis International},
The naturally occurring hormone calcitonin is a valued component of therapeutic programs currently available for osteoporosis. Calcitonin inhibits osteoclast-mediated bone resorption by decreasing osteoclast function, and possibly by reducing the osteoclast population through diminishing the differentiation of osteoclast progenitor cells. Whether calcitonin deficiency, or deficiency of calcitonin secretory reserve, contributes to the etiology of postmenopausal osteoporosis is currently unclear… CONTINUE READING
6 Citations
7 References
Similar Papers


Publications referenced by this paper.
Showing 1-7 of 7 references

Analgesic effect of intranasal salmon ealcitonin in the treatment of osteoporotic compression fractures

  • KK Pun, Chan LWL
  • Clin Ther 1989;11:205-9
  • 1989

Bone turnover in postmenopansal osteoporosis

  • R Civitelli, S Gonnelli, F Zacchei
  • J Clin Invest
  • 1988

Is bone loss the cause of osteoporotic fractures or its consequence? [abstract

  • RP Heaney, LV Avioli, CH Chestnut
  • J Bone Miner Res
  • 1988

Similar Papers

Loading similar papers…